中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Facile synthetic route to (2S,3S)-3-amino-2-hydroxy-4-phenylbutyric acid and its derivatives, the key intermediates for HIV protease inhibitors

文献类型:期刊论文

作者Lei, LJ; He, XC; Bai, DL
刊名SYNTHETIC COMMUNICATIONS
出版日期2005
卷号35期号:11页码:1535-1540
关键词AHPBA HIV protease inhibitors Nagata's reagent N-phthaloyl protecting group
ISSN号0039-7911
DOI10.1081/SCC-200058003
文献子类Article
英文摘要A facile and efficient route to (2S,3S)-3-amino-2-hydroxy-4-phenylbutyric acid and its derivative (4S,5S)-4-benzyl-5-hydroxymethyloxazolidin-2-one is presented. N-phthaloyl protected L-phenylalanine 1 was treated with thionyl chloride followed by hydrogenation of the acyl chloride 2 on Pd/C, giving (S)-2-phthalimido-3-phenylpropionaldehyde 3. Aldehyde 3 reacted with Nagata's reagent to afford 3-phthalimido-2-hydroxy-4-phenylbutyronitrile 4 as a diastereomeric mixture. After hydrolysis, protection, esterification, and reduction, 4 was transformed into the optically pure compound 7 in good yield.
WOS关键词BETA-AMINO ; ALDEHYDES
WOS研究方向Chemistry
语种英语
WOS记录号WOS:000230107300014
出版者TAYLOR & FRANCIS INC
源URL[http://119.78.100.183/handle/2S10ELR8/273973]  
专题中国科学院上海药物研究所
通讯作者Lei, LJ
作者单位Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Lei, LJ,He, XC,Bai, DL. Facile synthetic route to (2S,3S)-3-amino-2-hydroxy-4-phenylbutyric acid and its derivatives, the key intermediates for HIV protease inhibitors[J]. SYNTHETIC COMMUNICATIONS,2005,35(11):1535-1540.
APA Lei, LJ,He, XC,&Bai, DL.(2005).Facile synthetic route to (2S,3S)-3-amino-2-hydroxy-4-phenylbutyric acid and its derivatives, the key intermediates for HIV protease inhibitors.SYNTHETIC COMMUNICATIONS,35(11),1535-1540.
MLA Lei, LJ,et al."Facile synthetic route to (2S,3S)-3-amino-2-hydroxy-4-phenylbutyric acid and its derivatives, the key intermediates for HIV protease inhibitors".SYNTHETIC COMMUNICATIONS 35.11(2005):1535-1540.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。